StocksToTrade report covering Braskem SA ADR (BAK) market action, institutional positioning, and fundamental catalysts.
Why BAK Stock Traded Steady Today — RQD Quant Desk Flash
Braskem SA ADR (BAK) carries a Roarable Rating of D (Sell) with 45/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief)
Is BAK stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼
As of 2026-11-02, Braskem SA ADR (NYSE: BAK) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 45/100 at a spot price of $1.16 (0.00% 1D, market cap $462.4M). Pillar breakdown: Fundamental Cash Engine 12/20, Institutional 13F & Options Flow 3/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 8/20, and SEC Balance-Sheet Forensics 9/20. Across 270 tracked Materials issuers, BAK ranks #158 in composite RQD confidence.
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief)
How does BAK compare to LXFR and ASIX in the Materials sector?
▼
Within the Materials sector (Major Chemicals), BAK carries a Roarable D (45/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of —. By comparison, LXFR (Luxfer Holdings PLC) holds a C grade (65/100 RQD, P/E 60.0x, ROIC 8.2%, cap $462.1M) and ASIX (AdvanSix Inc.) posts a D grade (50/100 RQD, P/E 8.2x, ROIC 6.0%, cap $405.8M). Among the 5-stock peer group, ASIX leads on earnings multiple (8.2x) while LXFR leads on capital efficiency (8.2% ROIC).
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief)
What are the biggest fundamental strengths and SEC risk factors for BAK?
▼
For Braskem SA ADR (BAK), key quantitative strengths include Established market leader in Materials with deep daily trading liquidity. and sector rank #158 in Materials, while primary risk factors center on Company executives have done more routine share selling than personal cash buying lately. and Sensitive to high interest rates and tighter Federal Reserve market liquidity.. Institutional options positioning shows a 50% call / 50% put premium split.
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 7/9
SEC XBRL Trailing 12 Months: 0.3% FCF Margin ($12.9M FCF) & 52% Gross Margin
Put hedging (50% put share) caps near-term gamma upside (-16 pts vs max)
⚔️ Adversarial Opposing Case: What Could Spark a BAK Turnaround Squeeze
While BAK currently carries a cautious 45/100 (D) rating due to Whale & Options Positioning (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
Established market leader in Materials with deep daily trading liquidity.
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($1.67) and Max Pain ($1.22) forces dealer call-delta covering toward $5.66.
Forensic Repair Trigger: Halting share dilution (Disciplined Float (-0.40% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
Why BAK Stock Traded Steady Today — RQD Quant Desk Flash
Braskem SA ADR (BAK) slipped 0.00% to $1.16, trading at 5% of its 52-week range ($0.92 – $5.39). Stretched risk/reward at current multiples (steady margins) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 5% of its 52-week range ($0.92 – $5.39) with RSI-14 at 34.7 (NEUTRAL RANGE).
- ▸Volatility Profile: Historical 20-day realized swing band of ±12.5% around $1.16 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable D (Sell) backed by 52% gross margin and $12.9M annual free cash flow.
https://www.siam.in/ report covering Braskem SA ADR (BAK) market action, institutional positioning, and fundamental catalysts.
US session top movers: CLRO gained 54.77% and XXII fell 54.27%, leading individual stock gainers and losers with longer-term performance included.
Today's US session top percentage movers included sharp gains in small-cap and low-priced stocks and steep losses, led by RCT's 60.97% rise and XXII's 53.41% drop.
SGRY led gap-ups at 46.25% and XP led gap-downs at -50.48% in today's session, with SPRC, RENT, XNCR, XXII, DAICW and AGBK among notable gap movers.
Premarket trading is mixed ahead of today's US session, with LTRYW, SPRC and TGL among the largest gainers and XP, XXII and STNE among the largest losers.
Braskem S.A. faces debt distress, dilution risk, and political headwinds amid $11B restructuring. Click for this BAK update.
Brazilian stocks head for a record crash as EWZ sinks 25% premarket after Lula's run-off win, erasing its 2026 rally. Bank and fintech ADRs lead losses.
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring BAK)
- ✓Walkthrough of BAK's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
BAK Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on BAK today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for BAK. Explore sector supply chains on /butterfly.
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (BAK)
1. Head-to-Head Materials Peer Comparison (BAK vs. LXFR, ASIX, VHI, ADUR)
Industry: Major Chemicals (67 Tracked Issuers)Across 270 tracked Materials securities in the Roarable RQD universe, Braskem SA ADR (BAK) ranks #158 by composite RQD confidence (45/100, grade D) and #176 by equity capitalization ($462.4M). Within this direct 5-issuer industry benchmark cohort, ASIX leads on earnings valuation at 8.2x trailing P/E, while LXFR leads on capital efficiency and profitability with 8.2% ROIC and 23.2% gross margin. LXFR currently holds the highest overall quantitative score in the immediate peer group at 65/100 (C) compared with BAK at 45/100 (D).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| BAK
ACTIVE
Braskem SA ADR | D | 45/100 | — | — | — | 0.00% | $462.4M | Benchmark Subject |
| LXFR Luxfer Holdings PLC | C | 65/100 | 60.0x | 23.2% | 8.2% | -0.23% | $462.1M | /lxfr-vs-bak → |
| ASIX AdvanSix Inc. | D | 50/100 | 8.2x | — | 6.0% | +2.20% | $405.8M | /asix-vs-bak → |
| VHI Valhi Inc. | E | 28/100 | — | 14.2% | 6.2% | +0.86% | $396.2M | /vhi-vs-bak → |
| ADUR Aduro Clean Technologies Inc. | D | 45/100 | — | — | — | -1.07% | $367.4M | /adur-vs-bak → |
2. BAK Fundamental Profitability, Capital Efficiency & Balance-Sheet Forensics
TRAILING 12M & FORWARD QUANTITATIVE SNAPSHOTBraskem SA ADR (BAK) operates in Major Chemicals (Materials) with an equity capitalization of $462.4M, trailing P/E of N/A, forward P/E of N/A, and EV/EBITDA of N/A. Operating profitability registers a gross margin of —, operating margin of —, net profit margin of —, ROIC of —, and free cash flow yield of —, alongside an Altman Z-Score of N/A and Piotroski F-Score of N/A.
3. BAK Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs BAK stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-02, Braskem SA ADR (NYSE: BAK) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 45/100 at a spot price of $1.16 (0.00% 1D, market cap $462.4M). Pillar breakdown: Fundamental Cash Engine 12/20, Institutional 13F & Options Flow 3/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 8/20, and SEC Balance-Sheet Forensics 9/20. Across 270 tracked Materials issuers, BAK ranks #158 in composite RQD confidence.
How does BAK compare to LXFR and ASIX in the Materials sector?
Within the Materials sector (Major Chemicals), BAK carries a Roarable D (45/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of —. By comparison, LXFR (Luxfer Holdings PLC) holds a C grade (65/100 RQD, P/E 60.0x, ROIC 8.2%, cap $462.1M) and ASIX (AdvanSix Inc.) posts a D grade (50/100 RQD, P/E 8.2x, ROIC 6.0%, cap $405.8M). Among the 5-stock peer group, ASIX leads on earnings multiple (8.2x) while LXFR leads on capital efficiency (8.2% ROIC).
What are the biggest fundamental strengths and SEC risk factors for BAK?
For Braskem SA ADR (BAK), key quantitative strengths include Established market leader in Materials with deep daily trading liquidity. and sector rank #158 in Materials, while primary risk factors center on Company executives have done more routine share selling than personal cash buying lately. and Sensitive to high interest rates and tighter Federal Reserve market liquidity.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is BAK trading relative to its 50-day, 200-day, and 52-week technical levels?
BAK last traded at $1.16 (0.00% on volume of 2,665,804 shares), positioning the stock -30.54% below its 50-day simple moving average ($1.67) and -61.59% below its 200-day simple moving average ($3.02). Across its 52-week range of $0.92 to $5.39, BAK sits at the 5.4% percentile with a 14-day RSI of 34.7 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($1.02 to $1.30).
BAK Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is BAK stock moving today?
Why BAK Stock Traded Steady Today — RQD Quant Desk Flash. Stretched risk/reward at current multiples (steady margins) under elevated 10-year interest-rate pressure.
BAK — Braskem SA ADR: What the Facts Mean to a Prospective Investor
Roarable Rating Brief: What This Means to a Prospective Investor
Per the Roarable RQD rating, BAK scores 45 out of 100 with a letter grade of D and a verdict of "Roarable Sell — Underperform / Distribution Warning." Pillar by pillar: Fundamental Cash Engine scores 12 of 20, reflecting an ROIC of 0% and an FCF yield of 0%, which means the source data shows no measurable return on invested capital or free cash generation to support the valuation. Whale/13F Flow scores 3 of 20 for institutional accumulation and options positioning, the weakest pillar, signaling little institutional support in the data. Insider Conviction scores 9 of 20 based on SEC Form 4 and Congressional PTR cluster flow. Macro Regime Fit scores 8 of 20 with a beta of 1.0 and sector sensitivity noted. Forensic Balance Sheet scores 13 of 20, anchored by an Altman Z of 2.5, a Piotroski F of 6/9, and a Debt/Equity of 0.5.
For a prospective investor evaluating the stock today, the implication is that the rating frames BAK as a distribution-risk name rather than an accumulation candidate. The strongest pillar is the balance sheet, which is a stabilizing factor, but the absence of positive cash returns and weak institutional positioning mean the upside case rests on a turnaround that the source data does not evidence. The price of $1.16 sits near the bottom of a $0.92 to $5.39 52-week range, which can attract value-oriented interest, but the rating and the news flow point to downside pressure rather than a clean value entry.
Recent Catalysts & News Wire Analysis
- RISK WATCH (RED): A StocksToTrade report headlined "Braskem SA ADR Falls 37% on Debt Restructuring Plans," published 1h before the data timestamp. This is the most material item in the source data and points to debt restructuring as the central catalyst.
- MARKET WIRE (YELLOW): A second item referencing Madhav Copper (MCL.NS) and a ₹58.03 resistance level, sourced from siam.in, which is tagged as related to BAK. The relevance of this unrelated Indian copper-name headline to BAK is not established in the source data.
- Proprietary signals: None listed in the Butterfly Supply-Chain Graph.
Open Questions
- What are the terms and scope of the debt restructuring referenced in the RED-flagged news item, and how would they affect equity dilution or recovery?
- What are the reported revenue, operating income, net income, EPS, free cash flow, cash, and debt figures, since the financials section is empty?
- Why are margins and ROIC reported as 0% and does this reflect true zero performance or missing data?
- Who are the institutional holders and insider filers, since holders data is absent?
- How is the Madhav Copper headline connected to BAK, and is it relevant to the thesis?
BAK Live News Feed, Press Releases & Catalyst Wire
Real-time company headlines, analyst actions, and sector developments for Braskem SA ADR (BAK) • Click "Debate This Headline" to argue it in the Roar Pit below
StocksToTrade report covering Braskem SA ADR (BAK) market action, institutional positioning, and fundamental catalysts.
https://www.siam.in/ report covering Braskem SA ADR (BAK) market action, institutional positioning, and fundamental catalysts.
US session top movers: CLRO gained 54.77% and XXII fell 54.27%, leading individual stock gainers and losers with longer-term performance included.
Today's US session top percentage movers included sharp gains in small-cap and low-priced stocks and steep losses, led by RCT's 60.97% rise and XXII's 53.41% drop.
SGRY led gap-ups at 46.25% and XP led gap-downs at -50.48% in today's session, with SPRC, RENT, XNCR, XXII, DAICW and AGBK among notable gap movers.
Premarket trading is mixed ahead of today's US session, with LTRYW, SPRC and TGL among the largest gainers and XP, XXII and STNE among the largest losers.
BAK Bull vs. Bear Conversation Board — What's Your Call at $1.16?
🔥 Official Bull vs. Bear Debate: Is BAK (D • RQD 45/100) a Buy at $1.16?
Welcome to the BAK (Braskem SA ADR) Roar Pit. Current RQD Composite is 45/100 (Roarable Sell — Underperform / Distribution Warning) in Major Chemicals. Bulls point to operating leverage and sector positioning, while bears focus on macro rate sensitivity and margin execution. Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.
Pump the brakes on BAK — check the valuation vs. margin headwinds
Everyone in here is repeating the bull case on BAK, but look at what you are paying: current EV/EBITDA multiples with tightening sector spreads. Unless Braskem SA ADR expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.
BAK cash flow & RQD setup is being underpriced by the Street here
Looking at the 5-pillar RQD breakdown on BAK, the market is fixating on short-term headline noise in Major Chemicals and ignoring the balance sheet and cash flow trajectory. At $1.16 (52-wk range $0.92 - $5.39), any beat on forward guidance forces shorts and underweight funds to chase.